Related Experiment Video
Updated: Aug 4, 2026
12:04
Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 7, 2011
Deep brain stimulation for Parkinson's disease: association between stimulation parameters and cognitive performance
P Francel1, K Ryder, J Wetmore
1Neurosurgery Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK 721034, USA. paul-francel@ouhsc.edu
Stereotactic and Functional Neurosurgery
|November 24, 2004
Summary
Individualizing deep brain stimulation parameters for Parkinson's disease (PD) may optimize cognitive function. Adjusting stimulation settings, like amplitude and pulse width, can alter cognitive and behavioral responses in PD patients.
Area of Science:
- Neurology
- Neuroscience
- Neurosurgery
Background:
- Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a treatment for Parkinson's disease (PD).
- Cognitive and behavioral changes following STN-DBS in PD patients are inconsistent.
- Individualized stimulation parameters may influence these variable outcomes.
Purpose of the Study:
- To investigate the association between specific stimulation parameters and cognitive/behavioral outcomes in PD patients undergoing STN-DBS.
- To determine if modifying stimulation parameters can mitigate adverse cognitive effects while preserving motor benefits.
Main Methods:
- Analysis of neuropsychological performance data from 8 PD patients.
- Correlation analysis (Pearson r) between stimulation parameters (amplitude, pulse width, rate) and cognitive/behavioral measures.
- Systematic variation of stimulation parameters was explored.
Main Results:
- Each tested stimulation parameter demonstrated a significant association with distinct cognitive and behavioral measures.
- Specific parameter adjustments correlated with particular neuropsychological changes.
Conclusions:
- Stimulation parameter modification holds potential for managing adverse cognitive/behavioral effects of STN-DBS in PD.
- Tailoring stimulation settings may improve the overall efficacy and tolerability of DBS for Parkinson's disease.
